Luis Morano

17PUBLICATIONS
113CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical molecular engineering of nucleic acids and proteinsCardiology (incl. cardiovascular diseases)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 24, 2026
Immune Trajectories After Switch to Long-Acting Cabotegravir Plus Rilpivirine in the RELATIVITY Cohort.

|Oct 23, 2026
Long-term Effectiveness, Treatment Persistence, and Timing of Virological Failure With Long-Acting Cabotegravir Plus Rilpivirine in Real-World HIV Care: RELATIVITY Cohort.

|Aug 05, 2026
Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV.

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Jun 01, 2026
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People With HIV and Chronic Hepatitis B Virus Infection.

|Jan 28, 2026
Viruses Previously Classified as CRF146_BC, a Circulating Recombinant Form of HIV-1 Recently Reported in Brazil, Represent Different Recombinant Forms, One of Which Is Circulating in Spain.

Ana Donoso, María Moreno-Lorenzo, Elena Delgado

Pageof 3

Frequent Collaborators

4 joint publications

María Jesús Vivancos

3 joint publications

Noemí Cabello-Clotet

3 joint publications

Marta Montero-Alonso

3 joint publications

Aida López López